myPOLS Biotec

Konstanz, Germany Founded: 2014 • Age: 12 yrs Acquired By Medix Biochemica
Engineered DNA polymerases are supplied for molecular biology uses.

About myPOLS Biotec

myPOLS Biotec is a Healthcare company based in Konstanz (Germany) founded in 2014, and was acquired by Medix Biochemica in February 2022. Engineered DNA polymerases are supplied for molecular biology uses. Its chief executive, as recorded, is Ramon Kranaster. myPOLS Biotec offers products and services including HiDi DNA Polymerase, Taq DNA Polymerase, PlexTaq 5x qPCR Multiplex Master Mix, and Taq 2x PCR Master Mix. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics.

Company details

myPOLS Biotec was established in 2014 in Konstanz, Germany, within the biotechnology sector. Engineered DNA polymerases are developed and offered for molecular biology purposes. Focus is placed on advancing enzyme generations for applications such as pathogen detection, DNA and RNA diagnostics, forensics, and related fields. Operations center on research and provision of these specialized tools to support scientific and diagnostic needs.

  • Headquarters Konstanz, Germany
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website mypols.de
  • Acquired by Medix Biochemica (Feb 2022)
Key Metrics

Products & Services of myPOLS Biotec

myPOLS Biotec offers a comprehensive portfolio of products and services, including HiDi DNA Polymerase, Taq DNA Polymerase, PlexTaq 5x qPCR Multiplex Master Mix, and Taq 2x PCR Master Mix.

HiDi DNA Polymerase
DNA Polymerase

Enzyme optimized for allele-specific PCR applications

Taq DNA Polymerase
DNA Polymerase

Standard polymerase for general PCR amplification

PlexTaq 5x qPCR Multiplex Master Mix
qPCR Master Mix

Mix for multiplex quantitative PCR reactions

Taq 2x PCR Master Mix
PCR Master Mix

Ready-to-use mix for efficient PCR processes

Funding Insights of myPOLS Biotec

  • Total Rounds 2
  • Last Round Grant β€” $316,456
  • First Round $322,410

    (Jan 2020)

  • Investors Count 1

All 2 funding rounds of myPOLS Biotec with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2020$316,456Grant––
Jan 2020$322,410Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in myPOLS Biotec

myPOLS Biotec has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Medix Biochemica.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Develops and markets rapid diagnostic tests and bioreagents
1985medixbiochemica.comEspoo, Finland
Premium access

Investor details for myPOLS Biotec

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of myPOLS Biotec

1 people are tracked at myPOLS Biotec (1 in leadership).

NameRoleGroup
Ramon Kranaster
CEOLeadership
Premium access

Complete people profiles for myPOLS Biotec

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of myPOLS Biotec

4 dated milestones of myPOLS Biotec across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded myPOLS Biotec is founded.
  2. Funding First funding round of $322K.
  3. Funding Latest funding round, Grant, of $316K.
  4. Exit Acquired by Medix Biochemica.

Web traffic of myPOLS Biotec

The website of myPOLS Biotec (mypols.de) receives about 2.4K visits a month.

  • Monthly visits
    2.4K

    ▲ 300.4% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Mypols Biotec

Medix Biochemica Acquires myPOLS Biotec
Biotechnologynewsmagazine β€’ 4 years ago
Premium access

Complete news archive for myPOLS Biotec

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about myPOLS Biotec

myPOLS Biotec was founded in 2014 and raised its 1st funding round 6 years after it was founded.

myPOLS Biotec is headquartered in Konstanz, Germany. It is registered at Konstanz, Baden-wurttemberg, Germany.

Ramon Kranaster is the CEO of myPOLS Biotec, as recorded in our data.

myPOLS Biotec was established in 2014 in Konstanz, Germany, within the biotechnology sector. Engineered DNA polymerases are developed and offered for molecular biology purposes. Focus is placed on advancing enzyme generations for applications such as pathogen detection, DNA and RNA diagnostics, forensics, and related fields. Operations center on research and provision of these specialized tools to support scientific and diagnostic needs.

myPOLS Biotec offers HiDi DNA Polymerase, Taq DNA Polymerase, PlexTaq 5x qPCR Multiplex Master Mix, and Taq 2x PCR Master Mix.

myPOLS Biotec has 2 investors. Key investors include European Union, and Medix Biochemica.

Yes. myPOLS Biotec was acquired by Medix Biochemica in February 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available